Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma

Chee Chee Koh, Jin Cherng Sheu, Der Cherng Liang, Shu Huey Chen, Hsi C. Liu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The factors that affect survival in patients with stage 4 neuroblastoma vary. Several prospective and retrospective studies have provided conflicting conclusions regarding the benefit of combining aggressive chemotherapy with complete surgical resection. We analyzed our experience to evaluate the effect of complete surgical resection of the primary tumor on survival when disseminated disease has been controlled by chemotherapy. We retrospectively reviewed the medical records of 44 consecutive children with neuroblastoma treated between 1990 and 2000. Twenty-six children with stage 4 disease were enrolled. Most were treated with surgical resection combined with chemotherapy. The survival rate was compared based on the timing (primary versus delayed until chemotherapy had been given) and results of surgery (complete tumor resection, microscopic residual disease, and gross residual disease). The mean survival (52.8 months) of children with delayed complete surgical resection (CSR) was statistically superior to that of those with microscopic residual (20.8 months, p = 0.0111) or gross residual tumor (12.2 months, p = 0.0141). In the CSR group, 1-, 2-, 3-, and 5-year survival rates were 88%, 77%, 77%, and 65%, respectively, vs. 80%, 40%, 20%, and 0% in the microscopic residual group. In conclusion, complete resection of the primary tumor with no residual disease was associated with improved survival in children with advanced neuroblastoma whose metastatic disease had been controlled by chemotherapy.

Original languageEnglish
Pages (from-to)69-72
Number of pages4
JournalPediatric Surgery International
Volume21
Issue number2
DOIs
Publication statusPublished - Feb 2005
Externally publishedYes

Fingerprint

Neuroblastoma
Drug Therapy
Survival
Survival Rate
Neoplasms
Residual Neoplasm
Medical Records
Retrospective Studies
Prospective Studies

Keywords

  • Chemotherapy
  • Complete surgical resection
  • Neuroblastoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma. / Koh, Chee Chee; Sheu, Jin Cherng; Liang, Der Cherng; Chen, Shu Huey; Liu, Hsi C.

In: Pediatric Surgery International, Vol. 21, No. 2, 02.2005, p. 69-72.

Research output: Contribution to journalArticle

Koh, Chee Chee ; Sheu, Jin Cherng ; Liang, Der Cherng ; Chen, Shu Huey ; Liu, Hsi C. / Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma. In: Pediatric Surgery International. 2005 ; Vol. 21, No. 2. pp. 69-72.
@article{20846d4e4b31441ea5269b8d31fd23ee,
title = "Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma",
abstract = "The factors that affect survival in patients with stage 4 neuroblastoma vary. Several prospective and retrospective studies have provided conflicting conclusions regarding the benefit of combining aggressive chemotherapy with complete surgical resection. We analyzed our experience to evaluate the effect of complete surgical resection of the primary tumor on survival when disseminated disease has been controlled by chemotherapy. We retrospectively reviewed the medical records of 44 consecutive children with neuroblastoma treated between 1990 and 2000. Twenty-six children with stage 4 disease were enrolled. Most were treated with surgical resection combined with chemotherapy. The survival rate was compared based on the timing (primary versus delayed until chemotherapy had been given) and results of surgery (complete tumor resection, microscopic residual disease, and gross residual disease). The mean survival (52.8 months) of children with delayed complete surgical resection (CSR) was statistically superior to that of those with microscopic residual (20.8 months, p = 0.0111) or gross residual tumor (12.2 months, p = 0.0141). In the CSR group, 1-, 2-, 3-, and 5-year survival rates were 88{\%}, 77{\%}, 77{\%}, and 65{\%}, respectively, vs. 80{\%}, 40{\%}, 20{\%}, and 0{\%} in the microscopic residual group. In conclusion, complete resection of the primary tumor with no residual disease was associated with improved survival in children with advanced neuroblastoma whose metastatic disease had been controlled by chemotherapy.",
keywords = "Chemotherapy, Complete surgical resection, Neuroblastoma",
author = "Koh, {Chee Chee} and Sheu, {Jin Cherng} and Liang, {Der Cherng} and Chen, {Shu Huey} and Liu, {Hsi C.}",
year = "2005",
month = "2",
doi = "10.1007/s00383-004-1353-x",
language = "English",
volume = "21",
pages = "69--72",
journal = "Pediatric Surgery International",
issn = "0179-0358",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma

AU - Koh, Chee Chee

AU - Sheu, Jin Cherng

AU - Liang, Der Cherng

AU - Chen, Shu Huey

AU - Liu, Hsi C.

PY - 2005/2

Y1 - 2005/2

N2 - The factors that affect survival in patients with stage 4 neuroblastoma vary. Several prospective and retrospective studies have provided conflicting conclusions regarding the benefit of combining aggressive chemotherapy with complete surgical resection. We analyzed our experience to evaluate the effect of complete surgical resection of the primary tumor on survival when disseminated disease has been controlled by chemotherapy. We retrospectively reviewed the medical records of 44 consecutive children with neuroblastoma treated between 1990 and 2000. Twenty-six children with stage 4 disease were enrolled. Most were treated with surgical resection combined with chemotherapy. The survival rate was compared based on the timing (primary versus delayed until chemotherapy had been given) and results of surgery (complete tumor resection, microscopic residual disease, and gross residual disease). The mean survival (52.8 months) of children with delayed complete surgical resection (CSR) was statistically superior to that of those with microscopic residual (20.8 months, p = 0.0111) or gross residual tumor (12.2 months, p = 0.0141). In the CSR group, 1-, 2-, 3-, and 5-year survival rates were 88%, 77%, 77%, and 65%, respectively, vs. 80%, 40%, 20%, and 0% in the microscopic residual group. In conclusion, complete resection of the primary tumor with no residual disease was associated with improved survival in children with advanced neuroblastoma whose metastatic disease had been controlled by chemotherapy.

AB - The factors that affect survival in patients with stage 4 neuroblastoma vary. Several prospective and retrospective studies have provided conflicting conclusions regarding the benefit of combining aggressive chemotherapy with complete surgical resection. We analyzed our experience to evaluate the effect of complete surgical resection of the primary tumor on survival when disseminated disease has been controlled by chemotherapy. We retrospectively reviewed the medical records of 44 consecutive children with neuroblastoma treated between 1990 and 2000. Twenty-six children with stage 4 disease were enrolled. Most were treated with surgical resection combined with chemotherapy. The survival rate was compared based on the timing (primary versus delayed until chemotherapy had been given) and results of surgery (complete tumor resection, microscopic residual disease, and gross residual disease). The mean survival (52.8 months) of children with delayed complete surgical resection (CSR) was statistically superior to that of those with microscopic residual (20.8 months, p = 0.0111) or gross residual tumor (12.2 months, p = 0.0141). In the CSR group, 1-, 2-, 3-, and 5-year survival rates were 88%, 77%, 77%, and 65%, respectively, vs. 80%, 40%, 20%, and 0% in the microscopic residual group. In conclusion, complete resection of the primary tumor with no residual disease was associated with improved survival in children with advanced neuroblastoma whose metastatic disease had been controlled by chemotherapy.

KW - Chemotherapy

KW - Complete surgical resection

KW - Neuroblastoma

UR - http://www.scopus.com/inward/record.url?scp=13844294240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844294240&partnerID=8YFLogxK

U2 - 10.1007/s00383-004-1353-x

DO - 10.1007/s00383-004-1353-x

M3 - Article

C2 - 15647910

AN - SCOPUS:13844294240

VL - 21

SP - 69

EP - 72

JO - Pediatric Surgery International

JF - Pediatric Surgery International

SN - 0179-0358

IS - 2

ER -